nodes	percent_of_prediction	percent_of_DWPC	metapath
WF10—MAEA—blood vessel—stomach cancer	0.0955	0.124	CbGeAlD
WF10—CD163—hematopoietic system—stomach cancer	0.0571	0.0744	CbGeAlD
WF10—MAEA—hematopoietic system—stomach cancer	0.0509	0.0663	CbGeAlD
WF10—CD163—smooth muscle tissue—stomach cancer	0.0503	0.0655	CbGeAlD
WF10—MAEA—epithelium—stomach cancer	0.0465	0.0606	CbGeAlD
WF10—MAEA—smooth muscle tissue—stomach cancer	0.0448	0.0584	CbGeAlD
WF10—MAEA—pancreas—stomach cancer	0.0414	0.054	CbGeAlD
WF10—CD163—lymphoid tissue—stomach cancer	0.0402	0.0524	CbGeAlD
WF10—CD163—digestive system—stomach cancer	0.0397	0.0517	CbGeAlD
WF10—CD163—bone marrow—stomach cancer	0.0366	0.0477	CbGeAlD
WF10—MAEA—lymphoid tissue—stomach cancer	0.0358	0.0467	CbGeAlD
WF10—MAEA—digestive system—stomach cancer	0.0354	0.0461	CbGeAlD
WF10—CD163—endocrine gland—stomach cancer	0.0328	0.0427	CbGeAlD
WF10—MAEA—bone marrow—stomach cancer	0.0326	0.0425	CbGeAlD
WF10—CD163—liver—stomach cancer	0.0296	0.0385	CbGeAlD
WF10—MAEA—endocrine gland—stomach cancer	0.0292	0.0381	CbGeAlD
WF10—MAEA—liver—stomach cancer	0.0264	0.0343	CbGeAlD
WF10—CD163—lymph node—stomach cancer	0.0227	0.0295	CbGeAlD
WF10—Extravasation—Mitomycin—stomach cancer	0.0226	0.103	CcSEcCtD
WF10—MAEA—lymph node—stomach cancer	0.0202	0.0263	CbGeAlD
WF10—Lung disorder—Irinotecan—stomach cancer	0.0121	0.055	CcSEcCtD
WF10—Venous thrombosis—Capecitabine—stomach cancer	0.0106	0.0483	CcSEcCtD
WF10—Extravasation—Irinotecan—stomach cancer	0.00983	0.0446	CcSEcCtD
WF10—Extravasation—Fluorouracil—stomach cancer	0.00942	0.0427	CcSEcCtD
WF10—Infection—Floxuridine—stomach cancer	0.00892	0.0405	CcSEcCtD
WF10—Venous thrombosis—Epirubicin—stomach cancer	0.00741	0.0336	CcSEcCtD
WF10—Body temperature increased—Floxuridine—stomach cancer	0.0071	0.0322	CcSEcCtD
WF10—Oedema—Mitomycin—stomach cancer	0.00705	0.032	CcSEcCtD
WF10—Venous thrombosis—Doxorubicin—stomach cancer	0.00686	0.0311	CcSEcCtD
WF10—Extravasation—Docetaxel—stomach cancer	0.0068	0.0308	CcSEcCtD
WF10—Hyponatraemia—Irinotecan—stomach cancer	0.00625	0.0284	CcSEcCtD
WF10—Lung disorder—Methotrexate—stomach cancer	0.00604	0.0274	CcSEcCtD
WF10—Lung disorder—Epirubicin—stomach cancer	0.00565	0.0256	CcSEcCtD
WF10—Body temperature increased—Mitomycin—stomach cancer	0.00557	0.0253	CcSEcCtD
WF10—Lung disorder—Doxorubicin—stomach cancer	0.00523	0.0237	CcSEcCtD
WF10—Phlebitis—Docetaxel—stomach cancer	0.005	0.0227	CcSEcCtD
WF10—Extravasation—Methotrexate—stomach cancer	0.0049	0.0222	CcSEcCtD
WF10—Phlebitis—Capecitabine—stomach cancer	0.00484	0.022	CcSEcCtD
WF10—Extravasation—Epirubicin—stomach cancer	0.00459	0.0208	CcSEcCtD
WF10—Hyponatraemia—Docetaxel—stomach cancer	0.00432	0.0196	CcSEcCtD
WF10—Extravasation—Doxorubicin—stomach cancer	0.00424	0.0193	CcSEcCtD
WF10—Hyponatraemia—Capecitabine—stomach cancer	0.00419	0.019	CcSEcCtD
WF10—CD163—Scavenging of heme from plasma—APOA1—stomach cancer	0.00366	0.307	CbGpPWpGaD
WF10—Phlebitis—Epirubicin—stomach cancer	0.00337	0.0153	CcSEcCtD
WF10—Phlebitis—Doxorubicin—stomach cancer	0.00312	0.0142	CcSEcCtD
WF10—Oedema—Irinotecan—stomach cancer	0.00306	0.0139	CcSEcCtD
WF10—Infection—Irinotecan—stomach cancer	0.00304	0.0138	CcSEcCtD
WF10—Oedema—Fluorouracil—stomach cancer	0.00293	0.0133	CcSEcCtD
WF10—Hyponatraemia—Epirubicin—stomach cancer	0.00292	0.0132	CcSEcCtD
WF10—Infection—Fluorouracil—stomach cancer	0.00291	0.0132	CcSEcCtD
WF10—CD163—Scavenging of heme from plasma—ALB—stomach cancer	0.0029	0.243	CbGpPWpGaD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—stomach cancer	0.00276	0.231	CbGpPWpGaD
WF10—Hyponatraemia—Doxorubicin—stomach cancer	0.0027	0.0122	CcSEcCtD
WF10—Body temperature increased—Irinotecan—stomach cancer	0.00242	0.011	CcSEcCtD
WF10—Body temperature increased—Fluorouracil—stomach cancer	0.00232	0.0105	CcSEcCtD
WF10—Oedema—Docetaxel—stomach cancer	0.00212	0.0096	CcSEcCtD
WF10—Infection—Docetaxel—stomach cancer	0.0021	0.00954	CcSEcCtD
WF10—Oedema—Capecitabine—stomach cancer	0.00205	0.0093	CcSEcCtD
WF10—Infection—Capecitabine—stomach cancer	0.00204	0.00924	CcSEcCtD
WF10—Body temperature increased—Docetaxel—stomach cancer	0.00167	0.00759	CcSEcCtD
WF10—Body temperature increased—Capecitabine—stomach cancer	0.00162	0.00735	CcSEcCtD
WF10—Infection—Methotrexate—stomach cancer	0.00152	0.00688	CcSEcCtD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—stomach cancer	0.00146	0.122	CbGpPWpGaD
WF10—Oedema—Epirubicin—stomach cancer	0.00143	0.00648	CcSEcCtD
WF10—Infection—Epirubicin—stomach cancer	0.00142	0.00643	CcSEcCtD
WF10—Oedema—Doxorubicin—stomach cancer	0.00132	0.00599	CcSEcCtD
WF10—Infection—Doxorubicin—stomach cancer	0.00131	0.00595	CcSEcCtD
WF10—Body temperature increased—Methotrexate—stomach cancer	0.00121	0.00547	CcSEcCtD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—ALB—stomach cancer	0.00116	0.097	CbGpPWpGaD
WF10—Body temperature increased—Epirubicin—stomach cancer	0.00113	0.00512	CcSEcCtD
WF10—Body temperature increased—Doxorubicin—stomach cancer	0.00104	0.00474	CcSEcCtD
